Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,882 | -14,029 | -8,420 | -22,208 | -14,186 |
| Depreciation Amortization | 16 | 168 | 84 | 308 | 220 |
| Accounts receivable | N/A | 672 | -335 | -142 | -858 |
| Accounts payable and accrued liabilities | -699 | 703 | 951 | 1,169 | 1,504 |
| Other Working Capital | -724 | 2,187 | 605 | -5,966 | -548 |
| Other Operating Activity | 970 | -2,667 | 300 | 135 | -5,249 |
| Operating Cash Flow | $-3,319 | $-12,966 | $-6,815 | $-26,704 | $-19,117 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 250 | N/A | N/A | N/A | N/A |
| PPE Investments | -2 | -69 | -66 | -198 | -84 |
| Investing Cash Flow | $248 | $-69 | $-66 | $-198 | $-84 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,513 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | 8,500 | 8,500 | -2,085 | -911 |
| Common Stock Issued | N/A | 38 | 38 | 53,458 | 53,382 |
| Other Financing Activity | 0 | 0 | 0 | -927 | -927 |
| Financing Cash Flow | $1,513 | $8,538 | $8,538 | $50,446 | $51,544 |
| Exchange Rate Effect | N/A | -46 | -5 | 13 | -10 |
| Beginning Cash Position | 3,114 | 40,930 | 40,930 | 17,373 | 17,373 |
| End Cash Position | 1,556 | 36,387 | 42,582 | 40,930 | 49,706 |
| Net Cash Flow | $-1,558 | $-4,543 | $1,652 | $23,557 | $32,333 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,319 | -12,966 | -6,815 | -26,704 | -19,117 |
| Capital Expenditure | -2 | -69 | -66 | -198 | -84 |
| Free Cash Flow | -3,321 | -13,035 | -6,881 | -26,902 | -19,201 |